Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.
2 registered trials, newest registry update first. Showing only trials linked to Tesamorelin.
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| TH9507 in Patients With HIV-Associated Lipodystrophy NCT00123253 | Tesamorelin | Phase 3 | Completed | Theratechnologies | 412 | Nov 2006 | Nov 27, 2013 |
| TH9507 in Patients With HIV-Associated Lipodystrophy NCT00435136 | Tesamorelin | Phase 3 | Completed | Theratechnologies | 412 | Nov 2006 | Nov 27, 2013 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.
